ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,066.00
      -0.07%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,956.69
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AnaptysBio Inc (ANAB)

      7. AnaptysBio Inc (ANAB) News

      ANAB

      AnaptysBio (ANAB)

      AnaptysBio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ANAB
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/09/20244:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
      05/09/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
      05/09/20244:15PMGlobeNewswire Inc.Anaptys Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
      05/09/20244:10PMGlobeNewswire Inc.Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)NASDAQ:ANABAnaptysBio Inc
      05/09/20244:05PMGlobeNewswire Inc.Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli RoyaltiesNASDAQ:ANABAnaptysBio Inc
      05/06/202412:59PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ANABAnaptysBio Inc
      04/24/20249:00AMPR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:ANABAnaptysBio Inc
      03/11/20244:41PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANABAnaptysBio Inc
      03/11/20244:36PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANABAnaptysBio Inc
      03/11/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
      02/29/20249:15AMGlobeNewswire Inc.Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual MeetingNASDAQ:ANABAnaptysBio Inc
      02/14/202410:01AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
      02/14/20248:35AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
      01/31/20249:15AMGlobeNewswire Inc.Anaptys to Present at Guggenheim’s 6th Annual Biotechnology ConferenceNASDAQ:ANABAnaptysBio Inc
      01/09/20247:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/09/20247:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
      01/05/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
      11/27/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
      11/27/20234:15PMGlobeNewswire Inc.Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa PharmaceuticalsNASDAQ:ANABAnaptysBio Inc
      11/07/20234:15PMGlobeNewswire Inc.Anaptys Named a BioSpace 2024 Best Places to Work WinnerNASDAQ:ANABAnaptysBio Inc
      11/02/20234:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
      11/02/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
       Showing the most relevant articles for your search:NASDAQ:ANAB